Announced Thu, 18 Jun · 18:22 IST

Akums Drugs files BRSR for FY 2025-26

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹602.00
prior close
₹602.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2+0.1-0.4+2.1+3.0+2.0+0.9+3.9+4.9+13.5+12.4
Up moveDown movePending
AI summary

Akums Drugs and Pharmaceuticals has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 to the stock exchange. BRSR is a mandatory ESG disclosure required by SEBI for listed companies, covering environmental, social, and governance performance. This is a routine regulatory compliance filing with no new business update.

Likely market impact

Routine ESG compliance filing. No immediate material impact on stock or business, but offers investors a view of company sustainability metrics.